Journal article icon

Journal article

Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review.

Abstract:

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in terms of glycaemic control than standard biphasic human insulin 30 (BHI 30). In addition to gauging the treatment in terms of clinical evidence of benefits provided, it is also important to evaluate the strength of the evidence supporting the therapeutic improvements offered by BIAsp 30. In this paper,...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Tibaldi, J More by this author
Journal:
Clinical drug investigation
Volume:
27
Issue:
5
Pages:
299-324
Publication date:
2007
DOI:
EISSN:
1179-1918
ISSN:
1173-2563
URN:
uuid:8cac82e7-ec0a-4d11-925f-c6f29f78bfda
Source identifiers:
176392
Local pid:
pubs:176392

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP